Welcome to our dedicated page for Claritev news (Ticker: CTEV), a resource for investors and traders seeking the latest updates and insights on Claritev stock.
Claritev Corporation reports developments for a healthcare technology, data and insights company serving the U.S. healthcare system. The company provides technology-enabled solutions built on claims expertise, advanced analytics and AI to support affordability, price transparency, payment integrity, network optimization and benefits design for payers, employers, patients, providers and third parties.
Recurring news includes quarterly results, guidance, investor-day strategy, conference participation, AI-focused leadership and workflow updates, product-roadmap themes and Claritev Cares community initiatives. Company updates often connect its analytics platform with healthcare cost management, revenue integrity and vertical-market expansion.
Claritev (NYSE:CTEV) launched PHCS Novera, a primary network solution giving third-party administrators (TPAs) more control over health plan network design amid rising healthcare costs.
PHCS Novera combines regional provider depth with national access, aims to support cost containment strategies, and will roll out in select markets through 2026.
Claritev (NYSE:CTEV) announced that its management team will meet investors and present at the BofA Securities 2026 Global Health Care Conference in Las Vegas. The company will host a webcast of its presentation at 5:00 p.m. PT on Wednesday, May 13, 2026.
Claritev (NYSE: CTEV) reported Q1 2026 results for the quarter ended March 31, 2026. Revenues were $244.7 million, up 5.8% year-over-year. Net loss was $73.6 million. Adjusted EBITDA was $146.9 million (60.0% margin). Unrestricted cash totaled $21.3 million. The company updated full-year 2026 guidance modestly, raising the revenue floor to $985 million while keeping Adjusted EBITDA and free cash flow ranges unchanged.
Claritev (NASDAQ: CTEV) announced that Fernando Schwartz, Ph.D., Senior VP and Chief AI Officer, was named to the DataIQ 100 North America list for 2026. The recognition highlights Claritev’s work embedding AI into healthcare workflows to reduce administrative complexity, improve performance, and surface actionable insights at scale.
Claritev (NYSE: CTEV) will release its Q1 fiscal 2026 financial results before market open on Thursday, May 7, 2026 and will host a conference call at 8:00 AM ET. A live webcast, supplemental slide deck, and replay will be available in the Investor Relations section of the company's website.
Participants may join the webcast ten minutes early or dial in at 646-968-2525 with Conference ID 2181839 for an operator-assisted call.
Claritev (NYSE: CTEV) launched Claritev Cares, a nonprofit foundation expanding its longstanding rural health grant program and charitable initiatives. Applications for the Claritev Cares Rural Health Grant are open through June 1, 2026. Since 1995, Claritev has contributed over $700,000 via 100+ rural grants.
The foundation also supports food-as-medicine causes, veteran health, and global relief, including a $10,000 donation to World Central Kitchen, and emphasizes associate-driven priorities and measurable community impact.
Claritev (NYSE: CTEV) said members of its management team will meet investors at three events in March 2026, including virtual and in-person meetings and a webcast.
Events listed: Mizuho Virtual Healthcare Technology Conference (March 5, 2026), a Nephron Research Q&A webcast (March 6, 2026 at 11 a.m. ET), and Barclays 28th Annual Global Healthcare Conference (listed March 11, 2025 in Miami Beach) with one-on-one meetings; webcast access is via the company investor site.
Claritev (NYSE: CTEV) will host its 2026 Investor Day on Monday, March 16, 2026 at the New York Stock Exchange. The event starts at 1:00 p.m. ET and includes management presentations on growth strategy, vertical markets, product roadmap, and financial outlook.
A live webcast is available via registration at https://www.claritev.com/investor-day-2026/, and an archive replay will remain accessible for one year after the event.
Claritev (NYSE: CTEV) reported Q4 2025 revenue of $246.6 million, Q4 adjusted EBITDA of $151.3 million (61.4% margin), and Q4 net loss of $80.6 million. Full-year 2025 revenue was $965.4 million, adjusted EBITDA $602.6 million, and net loss $284.3 million.
The company initiated 2026 guidance: $980M–$1.0B revenue, adjusted EBITDA $605M–$615M, capex $160M–$170M, and free cash flow $0M–$10M. The board approved a $75M, five-year share repurchase program.
Claritev (NYSE: CTEV) will release fourth quarter and fiscal year 2025 results after market close on Monday, February 23, 2026 and host an earnings conference call the same day at 4:30 PM ET. Participants may pre-register to receive a unique PIN and calendar invite.
A live webcast, press release, and supplemental slide deck will be available in the Investor Relations section at investors.claritev.com/events-and-presentations. A replay will be archived on the same page after the call.